Effects of MIP-1α, MIP-3α, and MIP-3β on the induction of HIV gag-specific immune response with DNA vaccines

Molecular Therapy

Volumn 15, Issue 5, 2007, Pages 1007-1015

  Song, Ruijiang ^a   Liu, Shuqin ^a   Leong, Kam W ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; DNA VACCINE; GAG PROTEIN; GLYCOPROTEIN P 15095; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DENDRITIC CELL; DNA IMMUNIZATION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; INFLAMMATORY INFILTRATE; INOCULATION; MONOTHERAPY; MOUSE; NONHUMAN; PLASMID; PROTECTION; TH1 CELL; TH2 CELL; VIRUS IMMUNITY;

ANIMALS; CELL LINE; CHEMOTAXIS; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE PRODUCTS, GAG; HIV; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MACROPHAGE INFLAMMATORY PROTEINS; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; PLASMIDS; PROTEIN ISOFORMS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; VACCINIA VIRUS;

EID: 34247262226     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.sj.6300129     Document Type: Article

References (47)

1. Barouch, DH, Powers, J, Truitt, DM, Kishko, MG, Arthur, JC, Peyerl, FW et al. (2005). Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat Immunol 6: 247-252.
2. Wick, WD, Yang, OO, Corey, L and Self, SG (2005). How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyle kill? J Virol 79: 13579-13586.
3. Steinman, RM, Inaba, K, Turley, S, Pierre, P and Mellman, I (1999). Antigen capture, processing, and presentation by dendritic cells: Recent cell biological studies. Hum Immunol 60: 562-567.
4. Clark, GJ, Angel, N, Kato, M, Lopez, JA, MacDonald, K, Vuckovic, S et al. (2000). The role of dendritic cells in the innate immune system. Microbes Infect 2: 257-272.
5. Banchereau, J, and Steinman, RM (1998). Dendritic cells and the control of immunity. Nature 392: 245-252.
6. Banchereau, J, Schuler-Thurner, B, Palucka, AK and Schuler, G (2001). Dendritic cells as vectors for therapy. Cell 106: 271-274.
7. Kim, JJ, Nottingham, LK, Sin, JI, Tsai, A, Morrison, L, Oh, J et al. (1998). CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. J Clin Invest 102: 1112-1124.
8. Rossi, D and Zlotnik, A (2000). The biology of chemokines and their receptors. Annu Rev Immunol 18: 217-242.
9. Sozzani, S, Allavena, P, Vecchi, A and Mantovani, A (2000). Chemokines and dendritic cell traffic. J Clin Immunol 20: 151-160.
10. Mantovani, A, Allavena, P, Vecchi, A and Sozzani, S (1998). Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses. Int J Clin Lab Res 28: 77-82.
11. Lusso, P (2002). HIV and chemokines: Implications for therapy and vaccine. Vaccine 20: 1964-1967.
12. Ward, SG, Bacon, K and Westwick, J (1998). Chemokines and T lymphocytes: more than an attraction. Immunity 9: 1-11.
13. Xin, KQ, Lu, Y, Hamajima, K, Fukushima, J, Yang, J, Inamura, K et al. (1999). Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity. Clin Immunol 92: 90-96.
14. Boyer, JD, Kim, J, Ugen, K, Cohen, AD, Ahn, L, Schumann, K et al. (1999). HIV-1 DNA vaccines and chemokines. Vaccine 17 (suppl. 2): S53-S64.
15. Kim, JJ, Yang, JS, Dentchev, T, Dang, K and Weiner, DB (2000). Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines. J Interferon Cytokine Res 20: 487-498.
16. Youssef, S, Maor, G, Wildbaum, G, Grabie, N, Gour-Lavie, A and Karin, N (2000). C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis. J Clin Invest 106: 361-371.
17. Youssef, S, Wildbaum, G and Karin, N (1999). Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines. J Autoimmun 13: 21-29.
18. Lu, Y, Xin, KQ Hamajima, K, Tsuji, T, Aoki, I, Yang, J et al. (1999). Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1. Clin Exp Immunol 115: 335-341.
19. Eo, SK, Lee, S, Chun, S and Rouse, BT (2001). Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines. J Virol 75: 569-578.
20. Sumida, SM, McKay, PF, Truitt DM, Kishko, MG, Arthur, JC, Seaman, MS et al. (2004). Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. J Clin invest 114: 1334-1342.
21. Gough, M, Crittenden, M, Thanarajasingam, U, Sanchez-Perez, L, Thompson, J, Jevremovic, D et al. (2005). Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapy. J Immunol 174: 5766-5773.
22. Zibert, A, Balzer, S, Souquet, M, Quang, TH, Paris-Scholz, C, Roskrow, M et al. (2004). CCL3/MIP-1 alpha is a potent immunostimulator when coexpressed with interleukin-2 or granulocyte-macrophage colony-stimulating factor in a leukemia/lymphoma vaccine. Hum Gene Ther 15: 21-34.
23. Wildbaum, G, Netzer, N and Karin, N (2002). Plasmid DNA encoding IFN-gamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephallomyelitis. J Immunol 168: 5885-5892.
24. Sin, J, Kim, JJ, Pachuk, C, Satishchandran, C and Weiner, DB (2000). DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo. J Virol 74: 11173-11180.
25. Eo, SK, Lee, S, Kumaraguru, U and Rouse, BT (2001). Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands. Vaccine 19: 4685-4693.
26. Toka, FN, Gierynska, M and Rouse, BT (2003). Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1. J Virol 77: 12742-12752.
27. Biragyn, A, Belyakov, IM, Chow, YH, Dimitrov, DS, Berzofsky, JA and Kwak, LW (2002). DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses. Blood 100: 1153-1159.
28. Caux, C, Vanbervliet, B, Massacrier, C, Ait-Yahia, S, Vaure, C, Chemin, K et al. (2002). Regulation of dendritic cell recruitment by chemokines. Transplantation 73: S7-S11.
29. Yang, D, Howard, OM, Chen, Q and Oppenheim, JJ (1999). Cutting edge: immature dendritic cells generated from monocytes in the presence of TGF-beta 1 express functional C-C chemokine receptor 6. J Immunol 163: 1737-1741.
30. Sozzani, S, Allavena, P, Vecchi, A and Mantovani, A (1999). The role of chemokines in the regulation of dendritic cell trafficking. J Leukoc Biol 66: 1-9.
31. Liao, F, Rabin, RL, Smith, CS, Sharma, G, Nutman, TB and Farber, JM (1999). CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 162: 18-194.
32. Dieu, MC, Vanbervliet, B, Vicari, A, Bridon, JM, Oldham, E, Ait-Yahia, S et al. (1998). Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188: 373-386.
33. Casares, S, Inaba, K, Brumeanu, TD, Steinman, RM and Bona, CA (1997). Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J Exp Med 186: 1481-1486.
34. Menten, P, Wuyts, A and Van Damme, J (2002). Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 13: 455-481.
35. Belyakov, IM, Ahlers, JD, Brandwein, BY, Earl, P, Kelsall, BL, Moss, B et al. (1998). The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J Clin Invest 102: 2072-2081.
36. Furumoto, K, Soares, L, Engleman, EG and Merad, M (2004). Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. J Clin Invest 113: 774-783.
37. Greaves, DR, Wang, W, Dairaghi, DJ, Dieu, MC, Saint-Vis, B, Franz-Bacon, K et al. 1997). CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med 186: 837-844.
38. Baba, M, Imai, T, Nishimura, M, Kakizaki, M, Takagi, S, Hieshima, K et al. (1997). Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem 272 14893-14898.
39. Liao, F, Shirakawa, AK, Foley, JF, Rabin, RL and Farber, JM. (2002). Human B cells become highly responsive to macrophage-inflammatory protein-3 alpha/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding. J Immunol 168: 4871-4880.
40. Sierro, F, Dubois, B, Coste, A, Kaiserlian, D, Kraehenbuhl, JP and Sirard, JC (2001). Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci USA 98: 13722-13727.
41. Karpus, WJ, Lukacs, NW, Kennedy, KJ, Smith, WS, Hurst, SD and Barrett, TA (1997). Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158: 4129-4136.
42. Schrum, S, Probst, P, Fleischer, B and Zipfel, PF (1996). Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. J Immunol 157: 3598-3604.
43. Cook, DN, Beck, MA, Coffman, TM, Kirby, SL, Sheridan, JF, Pragnell, IB et al. (1995). Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269:1583-1585.
44. Kusakabe, K, Xin, KQ, Katoh, H, Sumino, K, Hagiwara, E, Kawamoto, S et al. (2000). The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by in HIV-1-specific DNA vaccine. J Immunol 164: 3102-3111.
45. Barouch, DH, Santra, S, Steenbeke, TD, Zheng, XX, Perry, HC, Davies, ME et al. (1998). Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J Immunol 161: 1875-1882.
46. Qiu, JT, Song, R, Dettenhofer, M, Tian, C, August, T, Felber, BK et al. (1999). Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. J Virol 73: 9145-9152.
47. Song, R, Liu, S, Adams, RJ and Leong, KW (2006). Enhancing efficacy of HIV gag DNA vaccine by local delivery of GM-CSF in murine and macaque models. J Interferon Cytokine Res 26: 380-389.